{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:21Z","timestamp":1792290981594,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00415-009-5156-9","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T12:05:19Z","timestamp":1242043519000},"page":"1519-1526","source":"Crossref","is-referenced-by-count":174,"title":["Efficacy of anti-epileptic drugs in patients with gliomas and seizures"],"prefix":"10.1007","volume":"256","author":[{"given":"M\u00e8lanie S. M.","family":"Breemen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Rijsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. B.","family":"Taphoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Walchenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zwinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Vecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"5156_CR1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archneur.1995.00540310091021","volume":"52","author":"PL Moots","year":"1995","unstructured":"Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717\u2013724","journal-title":"Arch Neurol"},{"key":"5156_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430. doi: 10.1016\/S1474-4422(07)70103-5","journal-title":"Lancet Neurol"},{"key":"5156_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/01.wnl.0000168903.09277.8f","volume":"65","author":"JF Hildebrand","year":"2005","unstructured":"Hildebrand JF, Lecaille CF, Perennes JF, Delattre JY (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212\u2013215. doi: 10.1212\/01.wnl.0000168903.09277.8f","journal-title":"Neurology"},{"key":"5156_CR4","first-page":"391","volume":"28","author":"W Wick","year":"2005","unstructured":"Wick W, Menn O, Meisner C, Steinbach J, Hermisson M, Tatagiba M, Weller M (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391\u2013396. doi: 10.1159\/000086375","journal-title":"Onkologie"},{"key":"5156_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, Van Donselaar CA, Vecht C (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586. doi: 10.1016\/S1059-1311(03)00096-7","journal-title":"Seizure"},{"key":"5156_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"S Eyal","year":"2004","unstructured":"Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M (2004) The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45:737\u2013744. doi: 10.1111\/j.0013-9580.2004.00104.x","journal-title":"Epilepsia"},{"key":"5156_CR7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","volume":"4","author":"XN Li","year":"2005","unstructured":"Li XN, Shu Q, Su JM, Perlaky L, Blaney SM, Lau CC (2005) Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther 4:1912\u20131922. doi: 10.1158\/1535-7163.MCT-05-0184","journal-title":"Mol Cancer Ther"},{"key":"5156_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109. doi: 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5156_CR9","first-page":"22","volume":"6","author":"A Chavez-Blanco","year":"2006","unstructured":"Chavez-Blanco A, Perez-Plasencia C, Perez-Cardenas E, Carrasco-Legleu C, Rangel-Lopez E, Segura-Pacheco B, Taja-Chayeb L, Trejo-Becerril C, Gonzalez-Fierro A, Candelaria M, Cabrera G, Duenas-Gonzalez A (2006) Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines. Cancer Cell Int 6(2):22\u201331. doi: 10.1186\/1475-2867-6-2","journal-title":"Cancer Cell Int"},{"key":"5156_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.nrl.0000250928.26044.47","volume":"12","author":"AD Norden","year":"2006","unstructured":"Norden AD, Wen PY (2006) Glioma therapy in adults. Neurologist 12:279\u2013292. doi: 10.1097\/01.nrl.0000250928.26044.47","journal-title":"Neurologist"},{"key":"5156_CR11","doi-asserted-by":"crossref","unstructured":"Stupp RF, Mason WPFAU, van den Bent M, van den Bent MJFAU, Weller M, Weller MF, Fisher BF, Taphoorn MJFAU, Belanger K, Belanger KF, Brandes AAFAU, Marosi C, Marosi CF, Bogdahn UF, Curschmann JF, Janzer RCFAU, Ludwin S, Ludwin SKFAU, Gorlia T, Gorlia TF, Allgeier AF, Lacombe DF, Cairncross JGFAU, Eisenhauer E, Eisenhauer EFAU, Mirimanoff R, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 10:987\u2013996. doi: 10.1056\/NEJMoa043330","DOI":"10.1056\/NEJMoa043330"},{"key":"5156_CR12","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/cncr.10357","volume":"94","author":"GA Sanden Van der","year":"2002","unstructured":"Van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, van der Maazen RW, Coebergh JW (2002) Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer 94:1548\u20131556. doi: 10.1002\/cncr.10357","journal-title":"Cancer"},{"key":"5156_CR13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.59.9_suppl_5.S21","volume":"59","author":"ST Herman","year":"2002","unstructured":"Herman ST (2002) Epilepsy after brain insult: targeting epileptogenesis. Neurology 59:S21\u2013S26","journal-title":"Neurology"},{"issue":"Suppl 3","key":"5156_CR14","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1990.tb05858.x","volume":"31","author":"GD Cascino","year":"1990","unstructured":"Cascino GD (1990) Epilepsy and brain tumors: implications for treatment. Epilepsia 31(Suppl 3):S37\u2013S44. doi: 10.1111\/j.1528-1157.1990.tb05858.x","journal-title":"Epilepsia"},{"key":"5156_CR15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2006.11.016","volume":"10","author":"HP Bootsma","year":"2007","unstructured":"Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP (2007) Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 10:296\u2013303. doi: 10.1016\/j.yebeh.2006.11.016","journal-title":"Epilepsy Behav"},{"key":"5156_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0404.2006.00647.x","volume":"113","author":"P Genton","year":"2006","unstructured":"Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammee G, Schlit AF, van Paesschen W (2006) Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial. Acta Neurol Scand 113:387\u2013394. doi: 10.1111\/j.1600-0404.2006.00647.x","journal-title":"Acta Neurol Scand"},{"key":"5156_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.seizure.2006.05.001","volume":"15","author":"P Kinirons","year":"2006","unstructured":"Kinirons P, McCarthy M, Doherty CP, Delanty N (2006) Predicting drug-resistant patients who respond to add-on therapy with levetiracetam. Seizure 15:387\u2013392. doi: 10.1016\/j.seizure.2006.05.001","journal-title":"Seizure"},{"key":"5156_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0074-7742(06)81016-0","volume":"81","author":"MJ Brodie","year":"2007","unstructured":"Brodie MJ, Stephen LJ (2007) Outcomes in elderly patients with newly diagnosed and treated epilepsy. Int Rev Neurobiol 81:253\u2013263. doi: 10.1016\/S0074-7742(06)81016-0","journal-title":"Int Rev Neurobiol"},{"key":"5156_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.21012","volume":"60","author":"DM Hermann","year":"2006","unstructured":"Hermann DM, Kilic E, Spudich A, Kramer SD, Wunderli-Allenspach H, Bassetti CL (2006) Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 60:489\u2013498. doi: 10.1002\/ana.21012","journal-title":"Ann Neurol"},{"key":"5156_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-6152-7","volume":"74","author":"C Calatozzolo","year":"2005","unstructured":"Calatozzolo C, Gelati M, Ciusani E, Sciacca FL, Pollo B, Cajola L, Marras C, Silvani A, Vitellaro-Zuccarello L, Croci D, Boiardi A, Salmaggi A (2005) Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol 74:113\u2013121. doi: 10.1007\/s11060-004-6152-7","journal-title":"J Neurooncol"},{"key":"5156_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","volume":"44","author":"R Coupez","year":"2003","unstructured":"Coupez R, Nicolas JM, Browne TR (2003) Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia 44:171\u2013178. doi: 10.1046\/j.1528-1157.2003.25302.x","journal-title":"Epilepsia"},{"key":"5156_CR22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404\u2013409. doi: 10.1016\/S1474-4422(03)00435-6","journal-title":"Lancet Neurol"},{"key":"5156_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","volume":"80","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 80:97\u2013100. doi: 10.1007\/s11060-006-9162-9","journal-title":"J Neurooncol"},{"key":"5156_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99\u2013102. doi: 10.1007\/s11060-005-9070-4","journal-title":"J Neurooncol"},{"key":"5156_CR25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clineuro.2007.05.017","volume":"109","author":"LM Lynam","year":"2007","unstructured":"Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, Wilkens JA (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109:634\u2013638. doi: 10.1016\/j.clineuro.2007.05.017","journal-title":"Clin Neurol Neurosurg"},{"key":"5156_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","volume":"28","author":"C Otoul","year":"2005","unstructured":"Otoul C, Arrigo C, Van Rijckevorsel K, French JA (2005) Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Clin Neuropharmacol 28:72\u201378. doi: 10.1097\/01.wnf.0000159956.87511.67","journal-title":"Clin Neuropharmacol"},{"key":"5156_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/seiz.2001.0497","volume":"10","author":"K Rijckevorsel Van","year":"2001","unstructured":"Van Rijckevorsel K, Boon PA (2001) The \u2018number needed to treat\u2019 with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). Seizure 10:235\u2013236. doi: 10.1053\/seiz.2001.0497","journal-title":"Seizure"},{"key":"5156_CR28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.critrevonc.2007.11.007","volume":"66","author":"MJ Bent Van den","year":"2008","unstructured":"Van den Bent MJ, Reni M, Gatta G, Vecht C (2008) Oligodendroglioma. Crit Rev Oncol Hematol 66:262\u2013272. doi: 10.1016\/j.critrevonc.2007.11.007","journal-title":"Crit Rev Oncol Hematol"},{"key":"5156_CR29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.64.5.581","volume":"64","author":"ML Veelen Van","year":"1998","unstructured":"Van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581\u2013587. doi: 10.1136\/jnnp.64.5.581","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5156-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5156-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5156-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:12:50Z","timestamp":1559056370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5156-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["5156"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5156-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1159586.620975","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}